Ardent Health, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Ardent Health, Inc. (ARDT) reported Net Income (Loss) Attributable to Noncontrolling Interest of $17.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-10
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $17.79M, a 21.81% decline year-over-year.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $18.64M, a 6.01% increase year-over-year.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $29.31M, a 9.81% increase year-over-year.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $24.68M, a 25.41% increase year-over-year.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $94.32M, a 5.55% increase from fiscal 2024.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $89.36M, a 19.04% increase from fiscal 2023.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $75.07M, a 1.82% decline from fiscal 2022.
- Ardent Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $76.46M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.79M 10-Q · filed 2026-08-10 | $36.43M 10-Q · filed 2026-08-10 | $65.73M derived: sum of 3 quarters · filed 2026-08-10 | $90.42M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $18.64M 10-Q · filed 2026-05-06 | $47.94M derived: sum of 2 quarters · filed 2026-05-06 | $72.63M derived: sum of 3 quarters · filed 2026-05-06 | $95.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $29.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $53.99M derived: sum of 2 quarters · filed 2026-03-16 | $76.74M derived: sum of 3 quarters · filed 2026-08-10 | $94.32M 10-K · filed 2026-03-16 |
| 2025-09-30 | $24.68M 10-Q · filed 2025-11-14 | $47.44M derived: sum of 2 quarters · filed 2026-08-10 | $65.02M 10-Q · filed 2025-11-14 | $91.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $22.75M 10-Q · filed 2026-08-10 | $40.33M 10-Q · filed 2026-08-10 | $67.02M derived: sum of 3 quarters · filed 2026-08-10 | $86.70M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $17.58M 10-Q · filed 2026-05-06 | $44.27M derived: sum of 2 quarters · filed 2026-05-06 | $63.95M derived: sum of 3 quarters · filed 2026-05-06 | $88.14M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $26.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $46.37M derived: sum of 2 quarters · filed 2026-03-16 | $70.56M derived: sum of 3 quarters · filed 2026-03-16 | $89.36M 10-K · filed 2026-03-16 |
| 2024-09-30 | $19.68M 10-Q · filed 2025-11-14 | $43.87M derived: sum of 2 quarters · filed 2025-11-14 | $62.68M 10-Q · filed 2025-11-14 | $77.61M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $24.19M 10-Q · filed 2025-08-06 | $42.99M 10-Q · filed 2025-08-06 | $57.93M derived: sum of 3 quarters · filed 2026-03-16 | $75.80M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $18.80M 10-Q · filed 2025-05-07 | $33.74M derived: sum of 2 quarters · filed 2026-03-16 | $51.61M derived: sum of 3 quarters · filed 2026-03-16 | $74.24M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $32.80M derived: sum of 2 quarters · filed 2026-03-16 | $55.43M derived: sum of 3 quarters · filed 2026-03-16 | $75.07M 10-K · filed 2026-03-16 |
| 2023-09-30 | $17.87M 10-Q · filed 2024-11-07 | $40.50M derived: sum of 2 quarters · filed 2024-11-07 | $60.14M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $22.63M 10-Q · filed 2024-08-14 | $42.27M 10-Q · filed 2024-08-14 | ||
| 2022-12-31 | $76.46M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| HCA Healthcare, Inc. (HCA) | United States | $93.934B | 15.49 |